Download PDF
Thromb Haemost 2000; 84(06): 1122-1123
DOI: 10.1055/s-0037-1614183
Letters to the Editor
Schattauer GmbH

Anti-Xa Monitoring: Inter-assay Variability

F. Depasse
1   LCL, Ivry-sur-Seine, France
,
M. Gilbert
2   Serbio-Diagnostica Stago, Gennevil liers, France
,
V. Goret
2   Serbio-Diagnostica Stago, Gennevil liers, France
,
N. Rolland
2   Serbio-Diagnostica Stago, Gennevil liers, France
,
M. M. Samama
› Author Affiliations
Further Information

Publication History

Received 02 March 2000

Accepted after revision 24 July 2000

Publication Date:
13 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Kitchen S, Iampietro R, Wolley AM, Preston FE. Anti-Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability. Thromb Haemost 1999; 82: 1289-93.
    Thieme ConnectPubMedSearch in Google Scholar
  • 2 Sié P, Aillaud MF, De Prost D, Droullé C, Forestier F, Guedj P, Juhan IVague, Polack B, Potron G, Roncato M, Roussi J, Sampol J, Aiach M. Measurement of low molecular weight heparin ex vivo activities in clinical laboratories using various anti-Xa assays: interlaboratory variability and requirement for an agreed low molecular weight heparin standard. Thromb Haemost 1987; 58: 879-83.
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Abildgaard U, Norrheim L, Larsen AE, Nesvold A, Sandset PM, Ødegaard OR. Monitoring therapy with LM W heparin: a comparison of three chromo genic substrate assays and the Heptest clotting assay. Haemostasis 1990; 20: 193-203.
    PubMedSearch in Google Scholar
  • 4 Houbouyan L, Boutiere B, Contant G, Dautzenberg MD, Fievet P, Potron G, Vassault A, Gourmelin Y. Validation protocol of analytical hemostasis systems: measurement of anti-Xa activity of low-molecular-weight heparins. Clin Chem 1996; 42: 1223-30.
    PubMedSearch in Google Scholar